Money

Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise

Pulse Reporter
Pulse Reporter
Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise




The brand new remedy targets intestine hormone GLP-1 but additionally mimics amylin, a hormone launched by the pancreas that suppresses starvation. Learn Extra

You Might Also Like

Easy methods to handle election anxiousness

The psychological well being of some children improved in the course of the pandemic

The way to watch, stream NFL Thursday Night time Soccer Week 12 video games dwell on-line free with out cable: NBC, Amazon

Elon Musk’s xAI is shopping for tools — and getting a tax break — for an X information middle in Atlanta, paperwork present

Trump assassination try suspect: Here is what we all know

Share This Article
Previous Article DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee
Next Article IHG Rewards Traveler Credit score Card assessment: Full particulars IHG Rewards Traveler Credit score Card assessment: Full particulars
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More News